MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Gait disturbance and olfactory dysfunction is associated with central cholinergic dysfunction in early Parkinson’s disease

E. Oh, Y. Lim, S. Park (Daejeon, Republic of Korea)

Meeting: 2017 International Congress

Abstract Number: 525

Keywords: Gait disorders: Pathophysiology, Olfactory dysfunction, Transcranial magnetic stimulation(TMS)

Session Information

Date: Tuesday, June 6, 2017

Session Title: Parkinson's Disease: Pathophysiology

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: We hypothesis that olfactory dysfunction, could be an independent predictor of gait disturbance in early PD.

Background: The pathophysiology of gait disturbance is not fully understood, but cholinergic dysfunction may be associated with gait as a non-dopaminergic contributor. Recently, central cholinergic activity is closely related with olfaction in PD patients, and it can be estimated with single transmagnetic stimulation (TMS) such as short-latency afferent inhibition (SAI).

Methods: All participants confirmed normal olfactory bulve with flexible fiberoptic laryngoscope and performed Korean version of the Sniffin’ stick (KVSS) test. The gait parameters during 10 m gait consisted of time for walking, number of steps, gait speed, stride length, stride time. SAI was measured by conditioning motor evoked potentials, elicited by TMS of the motor cortex, with electrical stimuli delivered to the contralateral median nerve at intervals ranging from N20 to N20+4ms. Unified Parkinson’s Disease Rating Scale (UPDRS), Hoehn and Yahr (H&Y) stage, Korean version of Mini-Mental Status Examination (K-MMSE), Korean version of Montreal Cognitive Assessment (K-MoCA), Beck depression inventory (BDI) were evaluated.

Results: 40 patients (normosmia:14, hyposmia:14, anosmia:12) data were analyzed. In aforementioned three groups, PD with anosmia group showed difference in age (p=0.01), UPDRS-III (p<0.01), H&Y stage (p=0.05), K-MMSE (p<0.01), and olfactory function tested by KVSS showed hierachial gradient between each group. In gait analysis, time for walking (p=0.01), number of steps (p=0.03), gait speed (p=0.02), and stride length (p=0.03) were significantly reduced in patients with anosmia group than hyposmia and normosmia group. An electrophysiologic parameters using SAI(%) N21ms (p=0.02), N22ms (p=0.05), N23ms (p<0.01), N24ms (p<0.01), and integrated SAI (p=0.01) showed significant difference among three groups. In correlation analysis gait speed showed highly positive association with TDI score (p=0.459, p<0.01).

Conclusions: In this study, olfactory dysfunction and gait disturbance was well related, in addition SAI which reflect the central cholinergic dysfunction showed difference as the degree of olfactory dysfunction. Therefore, central cholinergic dysfunction, especially olfactory dysfunction, could be a kind of non-dopaminergic contributor of gait disturbance in early PD patients.

To cite this abstract in AMA style:

E. Oh, Y. Lim, S. Park. Gait disturbance and olfactory dysfunction is associated with central cholinergic dysfunction in early Parkinson’s disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/gait-disturbance-and-olfactory-dysfunction-is-associated-with-central-cholinergic-dysfunction-in-early-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/gait-disturbance-and-olfactory-dysfunction-is-associated-with-central-cholinergic-dysfunction-in-early-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley